These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4087202)

  • 1. Accumulation and time to steady state for drugs subject to enterohepatic cycling: a stimulation study.
    Shepard TA; Gannaway DJ; Lockwood GF
    J Pharm Sci; 1985 Dec; 74(12):1331-3. PubMed ID: 4087202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of area under the curve for drugs subject to enterohepatic cycling.
    Shepard TA; Reuning RH; Aarons LJ
    J Pharmacokinet Biopharm; 1985 Dec; 13(6):589-608. PubMed ID: 3834073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of area under the curve measurements for drugs subject to enterohepatic cycling.
    Shepard TA; Reuning RH; Aarons LJ
    J Pharm Sci; 1985 Feb; 74(2):227-8. PubMed ID: 3989699
    [No Abstract]   [Full Text] [Related]  

  • 4. A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation.
    Steimer JL; Plusquellec Y; Guillaume A; Boisvieux JF
    J Pharm Sci; 1982 Mar; 71(3):297-302. PubMed ID: 7069584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of drugs subject to enterohepatic circulation.
    Chen HS; Gross JF
    J Pharm Sci; 1979 Jun; 68(6):792-4. PubMed ID: 458586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean residence time for drugs subject to enterohepatic cycling.
    Shepard TA; Lockwood GF; Aarons LJ; Abrahams ID
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):327-45. PubMed ID: 2810071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.
    Tse FL; Ballard F; Skinn J
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):455-61. PubMed ID: 7153875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and biopharmaceutic parameters during enterohepatic circulation of drugs.
    Colburn WA
    J Pharm Sci; 1982 Jan; 71(1):131-3. PubMed ID: 7057372
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic analysis of concentration-time data obtained following administration of drugs that are recycled in the bile.
    Colburn WA
    J Pharm Sci; 1984 Mar; 73(3):313-7. PubMed ID: 6585546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect modelling for drugs undergoing enterohepatic circulation.
    Höglund P; Ohlin M
    Eur J Drug Metab Pharmacokinet; 1993; 18(4):333-8. PubMed ID: 8020531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterohepatic recirculation of drugs as a determinant of therapeutic ratio.
    Duggan DE; Kwan KC
    Drug Metab Rev; 1979; 9(1):21-41. PubMed ID: 446267
    [No Abstract]   [Full Text] [Related]  

  • 12. Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.
    Hofmann AF; Molino G; Milanese M; Belforte G
    J Clin Invest; 1983 Apr; 71(4):1003-22. PubMed ID: 6682120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.
    Okour M; Brundage RC
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):493-504. PubMed ID: 30488336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-delay for two-compartment models used for study of enterohepatic circulation of drugs.
    Plusquellec Y; Bousquet L
    IEEE Trans Biomed Eng; 1984 Jun; 31(6):469-72. PubMed ID: 6735419
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of cholestasis on drug elimination: pharmacokinetics.
    Harrison LI; Gibaldi M
    J Pharm Sci; 1976 Sep; 65(9):1346-8. PubMed ID: 966151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug disposition and liver disease.
    Wilkinson GR; Schenker S
    Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficiency of enterohepatic circulation, its determination and influence on drug bioavailability.
    Horkovics-Kovats S
    Arzneimittelforschung; 1999 Oct; 49(10):805-15. PubMed ID: 10554656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the effective amount entering the body for drugs subject to enterohepatic recirculations.
    Plusquellec Y; Houin G
    Med Eng Phys; 1995 Apr; 17(3):172-6. PubMed ID: 7795853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stochastic approach in the evaluation of plasma curves with enterohepatic recycling.
    Tarr M; Eöry A
    Arch Toxicol Suppl; 1985; 8():208-10. PubMed ID: 3868351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An experimental design strategy for quantitating complex pharmacokinetic models: enterohepatic circulation with time-varying gallbladder emptying as an example.
    Wang YM; Reuning RH
    Pharm Res; 1992 Feb; 9(2):169-77. PubMed ID: 1553336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.